Table 1 Levels of cytokines IL-1, IL-6, and TNF-α in Wistar rats at 25 day after AIA initiation
From: Anti-inflammatory effect of different curcumin preparations on adjuvant-induced arthritis in rats
Group | Sex | IL-1, pg/ml | 95% CI | IL-6, pg/ml | 95% CI | TNF-α, pg/ml | 95% CI |
|---|---|---|---|---|---|---|---|
Control - | Male | < 31.3 | 0 - < 31.3 | < 31.3 | 0 - < 31.3 | < 39.1 | 0 - < 39.1 |
Male | < 31.3 | 0 - < 31.3 | < 31.3 | 0 - < 31.3 | < 39.1 | 0 - < 39.1 | |
Female | < 31.3 | 0–31.3 | < 31.3 | 0 - < 31.3 | < 39.1 | 0 - < 39.1 | |
Female | < 31.3 | < 31.3–50.1 | < 31.3 | < 31.3–56.9 | < 39.1 | 0 - < 39.1 | |
Control + | Male | 33.8 | < 31.3–76.0 | < 31.3 | < 31.3–68.1 | < 39.1 | < 39.1–67.1 |
Male | 54.0 | < 31.3–98.0 | 36.1 | < 31.3–73.9 | < 39.1 | < 39.1–66.9 | |
Female | 196.4 | 155.6–235,4 | 205.7 | 170.8–239.4 | 736.6 | 767.5–190.5 | |
Female | 51.5 | < 31.3–95.0 | 63.7 | < 31.3–99.5 | 226.1 | 190.5–261.4 | |
LIPO | Male | < 31.3 | < 31.3–39.9 | < 31.3 | < 31.3–35.4 | < 39.1 | 0 - < 39.1 |
Male | < 31.3 | < 31.3–54.0 | < 31.3 | < 31.3–43.8 | < 39.1 | 0 - < 39.1 | |
Male | < 31.3 | < 31.3–39.7 | < 31.3 | 0 - < 31.3 | < 39.1 | 0 - < 39.1 | |
Female | < 31.3 | 0 - < 31.3 | < 31.3 | 0 - < 31.3 | < 39.1 | 0 - < 39.1 | |
Female | < 31.3 | 0 - < 31.3 | < 31.3 | 0 - < 31.3 | < 39.1 | 0 - < 39.1 | |
Female | 37.9 | < 31.3–80.5 | < 31.3 | < 31.3–61.7 | 81.1 | 120.8 | |
MIC | Male | 41.4 | < 31.3–83.0 | 33.4 | < 31.4–72.1 | 80.9 | 41.7–118.0 |
Male | 114.9 | 73.4–155.0 | 127.7 | 91.5–162.5 | < 39.1 | 0 - < 39.1 | |
Male | < 31.3 | 0 - < 31.3 | < 31.3 | 0 - < 31.3 | 202.4 | 165.0–238.6 | |
Female | < 31.3 | 0 - < 31.3 | < 31.3 | 0 - < 31.3 | < 39.1 | 0 - < 39.1 | |
Female | 193.6 | 152.7–234.2 | 212.7 | 177.7–247.1 | 618.4 | 585.9–649.4 | |
Female | < 31.3 | < 31.3–57.4 | < 31.3 | < 31.3–41.1 | < 39.1 | < 39.1–75.0 | |
PIP | Male | 91.5 | 49.6–134.2 | 96.9 | 58.6–132.6 | < 39.1 | < 39.1–74.0 |
Male | < 31.3 | 0 - < 31.3 | < 31.3 | 0 - < 31.3 | < 39.1 | 0 - < 39.1 | |
Male | < 31.3 | < 31.3–61.5 | < 31.3 | < 31.3–48.1 | < 39.1 | 0 - < 39.1 | |
Female | < 31.3 | 0 - < 31.3 | < 31.3 | 0 - < 31.3 | < 39.1 | 0 - < 39.1 | |
Female | < 31.3 | 0 - < 31.3 | < 31.3 | 0 - < 31.3 | < 39.1 | < 39.1–52.3 | |
Female | 37.7 | < 31.3–79.3 | < 31.3 | 0 - < 31.3 | < 39.1 | 0 - < 39.1 | |
BAS | Male | 79.5 | 37.2–120.5 | 70.6 | < 31.3–107.3 | < 39.1 | < 39.1–73.2 |
Male | < 31.3 | < 31.3–62.2 | < 31.3 | < 31.3–50.0 | < 39.1 | 0 - < 39.1 | |
Male | 127.1 | 86.3–168.4 | 149.5 | 113.4–184.9 | < 39.1 | < 39.1–69.3 | |
Female | < 31.3 | 0 - < 31.3 | < 31.3 | 0 - < 31.3 | < 39.1 | < 39.1–55.9 | |
Female | 83.5 | 40.3–125.6 | 104.0 | 67.5–140.3 | 107.3 | 69.7–145.9 | |
Female | < 31.3 | 0 - < 31.3 | < 31.3 | < 31.1–34.1 | < 39.1 | 0 - < 39.1 |